Human antibody response to dengue virus: implications for dengue vaccine design
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1349-4147
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Human antibody response to dengue virus: implications for dengue vaccine design ; volume:44 ; number:1 ; day:14 ; month:3 ; year:2016 ; pages:1-6 ; date:12.2016
Tropical medicine and health ; 44, Heft 1 (14.3.2016), 1-6, 12.2016
- Urheber
-
Moi, Meng Ling
- Beteiligte Personen und Organisationen
-
Takasaki, Tomohiko
Kurane, Ichiro
SpringerLink (Online service)
- DOI
-
10.1186/s41182-016-0004-y
- URN
-
urn:nbn:de:1111-2016032620829
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moi, Meng Ling
- Takasaki, Tomohiko
- Kurane, Ichiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults
Dengue virus
Hypoxia enhances antibody‐dependent dengue virus infection
Identification of highly conserved, serotype-specific dengue virus sequences: implications for vaccine design
Systematic review of dengue vaccine efficacy
Correction to: Identification of highly conserved, serotype-specific dengue virus sequences: implications for vaccine design
Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome
Dengue encephalopathy in an adult due to dengue virus type 1 infection
In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections
Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties
Dengue-Virus-Infektionen : eine szientometrische Analyse
Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults
Dengue virus
Hypoxia enhances antibody‐dependent dengue virus infection
Identification of highly conserved, serotype-specific dengue virus sequences: implications for vaccine design
Systematic review of dengue vaccine efficacy
Correction to: Identification of highly conserved, serotype-specific dengue virus sequences: implications for vaccine design
Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome
Dengue encephalopathy in an adult due to dengue virus type 1 infection
In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections
Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties
Dengue-Virus-Infektionen : eine szientometrische Analyse
Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults
Dengue virus
Hypoxia enhances antibody‐dependent dengue virus infection
Identification of highly conserved, serotype-specific dengue virus sequences: implications for vaccine design
Systematic review of dengue vaccine efficacy
Correction to: Identification of highly conserved, serotype-specific dengue virus sequences: implications for vaccine design
Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome
Dengue encephalopathy in an adult due to dengue virus type 1 infection
In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections
Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties